Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma Journal Article
| Authors: | Taylor, R. C.; Patel, A.; Panageas, K. S.; Busam, K. J.; Brady, M. S. |
| Article Title: | Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma |
| Abstract: | Purpose: Tumor-infiltrating lymphocytes (TILs) are considered a manifestation of the host immune response to tumor, but the influence of TILs on outcome remains controversial. Studies evaluating the prognostic significance of TILs were published before routine examination of draining lymph nodes by sentinel lymph node (SLN) biopsy, the most important predictor of survival in patients with melanoma. The prognostic implications of TILs were re-evaluated in a large group of patients undergoing SLN biopsy at our institution. Patients and Methods: All patients who underwent SLN mapping for primary cutaneous melanoma between January 1996 and July 2005 were evaluated. Univariate and multivariate analyses were performed to assess factors that predict SLN positivity and survival. Factors analyzed included Breslow thickness, ulceration, anatomic site, sex, Clark level, age, mitotic rate, and the presence (brisk or nonbrisk) or absence of TIL. Results: Eight hundred eighty-seven patients underwent SLN mapping, and a SLN was identified in 875 patients (98.8%). The SLN was positive for tumor in 156 patients (17.6%). Multivariate analysis revealed that only Breslow thickness (P < .0001), ulceration (P = .0004), male sex (P = .03), and absent TILs (P = .0003) were independently predictive of the presence of SLN metastases. In melanomas with a brisk TIL infiltrate, the probability of a positive SLN was 3.9% as compared with 26.2% for melanomas in which TILs were absent. TILs were not an independent predictive factor for survival. Conclusion: The absence of TILs, together with increasing Breslow thickness, presence of ulceration and male sex, predicts SLN metastasis in patients undergoing SLN biopsy for primary cutaneous melanoma. © 2007 by American Society of Clinical Oncology. |
| Keywords: | adolescent; adult; cancer survival; child; controlled study; human tissue; aged; aged, 80 and over; middle aged; cancer surgery; survival rate; major clinical study; mortality; cancer recurrence; sentinel lymph node; sentinel lymph node biopsy; lymphadenectomy; mitosis; tumor associated leukocyte; lymphocytes, tumor-infiltrating; melanoma; neoplasm recurrence, local; skin neoplasms; pathology; prediction; histology; sex ratio; skin tumor; immunology; tumor recurrence; age distribution; lymphocyte |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 7 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-03-01 |
| Start Page: | 869 |
| End Page: | 875 |
| Language: | English |
| DOI: | 10.1200/jco.2006.08.9755 |
| PUBMED: | 17327608 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 48" - "Export Date: 17 November 2011" - "CODEN: JCOND" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work